Trekk Venture Partners' Brian Gallagher gives an update on the venture market
- blonca9
- Sep 18, 2023
- 1 min read
Brian Gallagher describes what it is like raising venture funds in biotech today and also offers areas of science that he is focused on.
Also look for unique social pages for BiotechTV U.
Genezen is a contract development and manufacturing organization (CDMO) with unique technical expertise in lentiviral, retroviral, and adeno-associated viral vectors. Offering process development, GMP viral vector manufacturing, and analytics, we are dedicated to helping you deliver safe, pure, and potent advanced therapies to the patients who need them.